![The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma | SpringerLink The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-022-05704-0/MediaObjects/259_2022_5704_Fig2_HTML.png)
The diagnostic accuracy and clinical impact of FDG-PET/CT follow-up for patients on adjuvant immunotherapy for high-risk malignant melanoma | SpringerLink
Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment | Haematologica
Adaptation of Nonrevascularized Human Hibernating and Chronically Stunned Myocardium to Long-Term Chronic Myocardial Ischemia
Syddansk Universitet Bone healing in multiple myeloma A prospective evaluation of the impact of first-line anti-myeloma treatmen
![Abstract 2429: Non-Revascularized Human Hibernating and Chronically Stunned Myocardium Can Adapt to Long-Term Chronic Ischemia | Circulation Abstract 2429: Non-Revascularized Human Hibernating and Chronically Stunned Myocardium Can Adapt to Long-Term Chronic Ischemia | Circulation](https://www.ahajournals.org/cms/asset/37aead04-fad6-4a92-a7f3-5908db27f31b/2429f1.jpg)
Abstract 2429: Non-Revascularized Human Hibernating and Chronically Stunned Myocardium Can Adapt to Long-Term Chronic Ischemia | Circulation
![Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile](https://www.researchgate.net/profile/Oke-Gerke/publication/358421595/figure/fig1/AS:1159082346061827@1653358174756/Bar-chart-showing-the-number-of-FDG-PET-CT-scans-each-patient-received_Q320.jpg)
Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile
Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment | Haematologica
Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high- dose chemotherapy
![Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile](https://i1.rgstatic.net/ii/profile.image/555134604111872-1509365811635_Q512/Paw-Holdgaard.jpg)
Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile
![Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile](https://www.researchgate.net/profile/Paw-Holdgaard/publication/305039331/figure/fig3/AS:613998449938465@1523400046891/figure-fig3_Q320.jpg)
Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile
![Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile](https://www.researchgate.net/profile/Paw-Holdgaard/publication/305039331/figure/fig1/AS:613998449922060@1523400046594/figure-fig1_Q320.jpg)
Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile
![Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile](https://www.researchgate.net/profile/Paw-Holdgaard/publication/305039331/figure/fig2/AS:613998449942550@1523400046646/figure-fig2_Q320.jpg)
Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile
Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high- dose chemotherapy
Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm. A single-case report | Haematologica
![Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile Paw HOLDGAARD | Medical Doctor | Sygehus Lillebaelt, Vejle | Department of Nuclear Medicine | Research profile](https://www.researchgate.net/profile/Oke-Gerke/publication/358421595/figure/fig4/AS:1159082346065922@1653358174839/Distribution-of-true-and-false-positive-lesions-at-the-3-month-scan-a-A-total-of-26-true_Q320.jpg)